SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: billkirn who wrote (4021)4/12/1998 2:30:00 PM
From: JR  Respond to of 6136
 
Bill,
I agree that current earnings may not run the stock price up, unless they exceed estimates by a significant percentage. But, with a pretty steady market share (30%) of a growing market, and the recent approvals in Europe and Japan, I hope that they won't disappoint. Agouron is due for some news on the Rhinovirus very soon. Perhaps that would stimulate further interest and credibility in their pipeline. Any thoughts? Thanks.

JR